| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.011 | 0.8 |